Tempus, a leading technology company advancing precision medicine through the collection and analysis of molecular and clinical data, announced today an additional $200M financing at a value of $3.1 billion dollars. The investors include Baillie Gifford, Franklin Templeton, NEA, Novo Holdings, Revolution Growth, and funds and accounts managed by T. Rowe Price. With this latest round, the company has raised $520 million since its founding in September 2015.Founded in 2015, Tempus has the largest
Read More
Life Sciences - Pharma | News, Analysis, Insights - HIT Consultant
Healthcare M&A Survey: Health IT Represents the Richest Opportunity in Sector
Most healthcare mergers and acquisitions (M&A) professionals see a positive outlook for healthcare and life sciences deals next year, even as political uncertainty will be the biggest factor to upend transactions, according to a recent Merrill Insight poll of global M&A professionals.According to the poll, which included more than 200 respondents from the Americas and Europe, the Middle East and Africa (EMEA), 52% of respondents believe that the M&A market is headed in a positive
Read More
BHE Raises $78M To Expand Real-World Evidence Analytics Platform
BHE, a Boston, MA-based innovative healthcare analytics company, today announced a $78 million minority growth investment led by Silversmith Capital Partners (“Silversmith”) and Leerink Transformation Partners (“LTP”). Instant Health DataThe use of real-world evidence (RWE) has grown rapidly within life sciences companies over the last several years, supported by the proliferation of large datasets, new computing technologies, and interest by both payers and regulatory agencies in understanding
Read More
MATTER, rMark Bio Launch AI-Powered Healthcare Innovation Matchmaker, Origin
MATTER, a Chicago, IL-based healthcare incubator and innovation hub, and rMark Bio, a life sciences AI company announced the launch of Origin™ — a new product to further accelerate healthcare innovation via collaboration. Exclusively available to the MATTER community of startup members and partner organizations, Origin combines the power of machine learning with MATTER’s expertise in vetting, coaching and convening to match pharmaceutical companies, payers and health systems with the right
Read More
Pfizer, McKesson, Others Join MediLedger’s Blockchain Project Working Group
Leading life sciences and healthcare companies Pfizer Inc., McKesson Corporation, AmerisourceBergen Corporation, and Premier Inc. have joined the MediLedger Project Contracting and Chargebacks working group, a second working group running in parallel to the ongoing DSCSA working group started in 2017. MediLedger is an initiative of Chronicled, Inc., a San Francisco-based technology company, that builds blockchain-powered ecosystems and supply chain solutions.Network VisionMediLedger uses
Read More
7 Trends Accelerating “TechBio” – The Life Sciences and Computer Sciences Convergence
We are now living in what I’m calling the
TechBio revolution. That’s not a typo that should read BioTech, but rather a
new way of looking at the convergence of technology and biology.
TechBio is defined as an engineering-first approach of biological processes for industrial, and other purposes, especially the genetic manipulation of microorganisms for the production of antibiotics, hormones, and so on. A process that uses AI and data-enabled discovery to complement the exploration of
Read More
HIMSS Appoints Dr. Sebastian Krolop As Global Chief Operating & Strategy Officer
HIMSS, has announced the
appointment of Dr. Sebastian Krolop, MD, PhD, MSc, to the role of
chief operating & strategy officer (COSO). Under his leadership as COSO, Dr. Krolop will lead the alignment of HIMSS’s
operational goals with the organization’s strategic plan. In addition, he will
guide the direction of HIMSS
Analytics, HIMSS
Media and foster additional support services in international
markets.
Dr. Krolop Background/Experience
Dr. Krolop comes to the organization
Read More
Massachusetts Launches Digital Health ‘Sandbox’ Program for Startups
On Wednesday, Massachusetts Governor Charlie Baker joined members of the Massachusetts Digital Health Council to announce a new program to drive the growth of innovative startups in the state, helping them access unique R&D facilities in the state. The announcement was made at Worcester Polytechnic Institute’s PracticePoint research, development and commercialization alliance, the first R&D ‘sandbox’ selected to host startups as part of the program. That facility was the recipient of a
Read More
7 Healthcare Trends Advancing and Impacting Growth Initiatives in 2019
Definitive Healthcare, a provider of data, intelligence, and analytics on the healthcare provider market, today released results from its 2019 Healthcare Trends Survey. Definitive Healthcare polled over 1,000 healthcare leaders across the provider, biotech, financial services, staffing, life sciences, IT, and consulting verticals to determine which trends they felt were most important, heading into 2019.Here are seven healthcare trends advancing and impacting growth initiatives in the healthcare
Read More
PathAI Lands $60M to Accelerate AI-Powered Pathology Platform
PathAI, a Boston, MA-based provider of AI-powered pathology platform has raised $60M in Series B funding led by General Atlantic with strong participation from General Catalyst and other existing investors. General Atlantic Managing Director Dr. Michelle Dipp will be joining PathAI’s board of directors.Advanced Learning Towards Faster More Accurate Diagnosis of DiseaseCo-founded by Chief Executive Officer Dr. Andy Beck in 2016 with the mission to offer faster, safer and more powerful solutions
Read More
